Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

There have never been more options for things to buy. Google is betting AI is how shoppers will make decisions. There have never been more options for things to buy. Google is betting AI is how ...

WASHINGTON, Nov 12 (Reuters) - President Donald Trump is committed to providing Americans a $2,000 check using money that has come into government coffers from Trump's tariffs, the White House said on ...

Scott Bessent has given an update on the $2,000 stimulus checks President Donald Trump proposed paying out using the revenue raised from his tariffs. In an interview with ABC News on Sunday, the ...

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...

In Hans Christian Andersen's folktale, The Emperor's New Clothes, when a child cries out that the emperor is naked, he isn't revealing a secret. Everyone already knows it. What changes in that instant ...

“Interviews are NOT real anymore.” So reads the opening caption of a TikTok posted in September, punctuated by the skull-and-crossbones emoji. In the video, a young woman interviews for a job on a ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

Kara Alaimo is a professor of communication at Fairleigh Dickinson University. Her book “Over the Influence: Why Social Media Is Toxic for Women and Girls — And How We Can Take It Back” was published ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...